source
- Windward prices $175M IPO to advance China-licensed lung drugsThe Swiss biotech has two prospects it sees as having the potential to outcompete AstraZeneca and Amgen's blockbuster asthma treatment Tezspire.BioPharma Dive · 45m ago↗ source
- Scientists release detailed basal ganglia cell map, uncover new neuron linked to schizophreniaScientists from a large international collaboration have created the most detailed map of the basal ganglia, a brain region that coordinates movement and emotion. The effort profiled over 25 millio…
- FDA faces over 1,000 vacant positions as staffing shortage strains pharma oversight